pravastatin has been researched along with Reperfusion Injury in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZL; Deng, F; Hu, JJ; Li, C; Lin, ZB; Liu, KX; Liu, WF; Liu, Y; Luo, SD; Sun, QS; Yan, ZZ; Yang, X; Yao, ZW; Zhao, BC | 1 |
| Chen, J; Li, H; Li, N; Liu, C; Sun, J; Wang, C | 1 |
| Barron, FE; Burridge, PW; Churko, JM; Diecke, S; Gold, JD; Gu, M; He, C; Hu, S; Kooreman, NG; Lee, J; Mordwinkin, NM; Ong, SG; Wu, H; Wu, JC | 1 |
| Burne-Taney, MJ; Ikeda, M; Ito, K; Kumagai, K; Mori, M; Rabb, H; Sharyo, S; Uchida, K; Yokota-Ikeda, N | 1 |
| Haslinger-Löffler, B | 1 |
| Honda, Y; Honjo, M; Kiryu, J; Nishijima, K; Sawamura, T; Tanihara, H; Yue, BY | 1 |
| Bharwani, S; Grisham, MB; Harada, H; Hines, IN; Hoffman, JM; Lefer, DJ; Pavlick, KP; Wolf, RE | 1 |
| Chandler, JR; Dillon, JP; Laing, AJ; McGuinness, A; Redmond, HP; Wang, JH | 1 |
| Dichgans, M; Hamann, GF; Trinkl, A; Vosko, MR; Wunderlich, N | 1 |
| Abolhassani, F; Ebrahimnejad, M; Jahanzad, I; Nouri, M; Pourabbasi, A | 1 |
| Agardh, CD; Agardh, E; Gustavsson, C; Hagert, P | 1 |
| Bouchier-Hayes, DJ; Chen, G; Joyce, M; Kelly, CJ | 1 |
| Bouchier-Hayes, D; Chen, G; Joyce, M; Kelly, C; Leahy, A; Winter, D | 1 |
| Do, GM; Kwon, O; Lim, EJ; Shin, JH | 1 |
1 trial(s) available for pravastatin and Reperfusion Injury
| Article | Year |
|---|---|
Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase.
Topics: Analysis of Variance; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Male; Neutrophils; Nitric Oxide Synthase; Peroxidase; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Up-Regulation | 2001 |
13 other study(ies) available for pravastatin and Reperfusion Injury
| Article | Year |
|---|---|
Gut Microbial Metabolite Pravastatin Attenuates Intestinal Ischemia/Reperfusion Injury Through Promoting IL-13 Release From Type II Innate Lymphoid Cells
Topics: Animals; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Immunity, Innate; Interleukin-1 Receptor-Like 1 Protein; Interleukin-13; Interleukin-33; Intestinal Diseases; Lymphocytes; Male; Mice; Mice, Knockout; Pravastatin; Reperfusion Injury | 2021 |
Pravastatin Decreases Infarct Size Induced by Coronary Artery Ischemia/Reperfusion with Elevated eNOS Expression in Rats.
Topics: Animals; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA | 2018 |
Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.
Topics: Analysis of Variance; Animals; Apoptosis; Cell Differentiation; Diet, High-Fat; Endothelial Cells; Enzyme Inhibitors; Fibroblasts; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induced Pluripotent Stem Cells; Injections, Intramuscular; Ischemia; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Oxidative Stress; Pravastatin; Proto-Oncogene Proteins c-akt; Random Allocation; Reperfusion Injury; Signal Transduction | 2015 |
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.
Topics: Acute Kidney Injury; Animals; Apolipoproteins E; Cholesterol; Creatinine; Enzyme Inhibitors; Farnesyltranstransferase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Kidney; Male; Methionine; Mevalonic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Pravastatin; Reperfusion Injury; Terpenes | 2008 |
Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function.
Topics: Animals; Cholesterol; Disease Models, Animal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Interleukin-6; Kidney; Mice; Pravastatin; Reperfusion Injury | 2008 |
Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina.
Topics: Acridine Orange; Animals; Apoptosis; Cell Adhesion; Endothelium, Vascular; Fluorescent Dyes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Intercellular Adhesion Molecule-1; Leukocytes; Male; Neurons; Neuroprotective Agents; P-Selectin; Polymerase Chain Reaction; Pravastatin; Pyridines; Rats; Rats, Long-Evans; Reperfusion Injury; Retinal Diseases; Retinal Vessels; RNA, Messenger | 2002 |
Sexual dimorphism in reduced-size liver ischemia and reperfusion injury in mice: role of endothelial cell nitric oxide synthase.
Topics: Animals; Female; Ischemia; Liver; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pravastatin; Reperfusion Injury; Sex Characteristics | 2003 |
Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle, Skeletal; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tourniquets | 2006 |
Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion.
Topics: Animals; Basement Membrane; Biomarkers; Blood-Brain Barrier; Cerebral Arterial Diseases; Cerebral Arteries; Cerebral Infarction; Collagen Type IV; Disease Models, Animal; Down-Regulation; Hemoglobins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperemia; Ischemic Attack, Transient; Male; Microcirculation; Pravastatin; Rats; Rats, Wistar; Reperfusion Injury | 2006 |
Pravastatin prevents ischemia-reperfusion injury in rat sciatic nerve.
Topics: Animals; Axons; Cytoprotection; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Neuroprotective Agents; Oxidative Stress; Peripheral Nerves; Pravastatin; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sciatic Neuropathy; Time Factors; Treatment Outcome; Wallerian Degeneration | 2006 |
Inflammatory markers in nondiabetic and diabetic rat retinas exposed to ischemia followed by reperfusion.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Docosahexaenoic Acids; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Pravastatin; Rats; Rats, Wistar; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2008 |
Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion.
Topics: Animals; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Kidney; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Reperfusion Injury | 2001 |
Protective effects of Acanthopanax divaricatus vat. albeofructus and its active compound on ischemia-reperfusion injury of rat liver.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Eleutherococcus; Furans; Glucosides; Ischemia; L-Lactate Dehydrogenase; Lignans; Liver; Male; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2013 |